{
    "2019-10-27": [
        [
            {
                "time": "",
                "original_text": "【爱尔眼科】19Q3+公告点评：业绩加速成长，边界不断外延",
                "features": {
                    "keywords": [
                        "爱尔眼科",
                        "19Q3",
                        "业绩加速成长",
                        "边界外延"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医疗"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "【中信建投医药|行业周报】基金三季度持仓：重点领域龙头获得青睐",
                "features": {
                    "keywords": [
                        "中信建投",
                        "医药",
                        "三季度持仓",
                        "龙头",
                        "基金"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "公募基金2019Q3医药持仓分析【兴证医药】",
                "features": {
                    "keywords": [
                        "公募基金",
                        "2019Q3",
                        "医药",
                        "持仓分析"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "",
                "original_text": "季报看台|核心资产价格走势业绩为王：为何平安片仔癀跌恒瑞大涨",
                "features": {
                    "keywords": [
                        "季报",
                        "核心资产",
                        "价格走势",
                        "业绩",
                        "平安",
                        "片仔癀",
                        "恒瑞"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "金融"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "mixed",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "mixed"
                }
            }
        ]
    ]
}